Pharmafile Logo
Pharmafocus logo
Advanced Search

heart

Showing 7 posts of 22 posts found.

3d printing image

3D printed hearts ‘on the horizon’

May 8, 2014
Medical Communications, Sales and Marketing 3D, heart, louisville, printing, williams

The ‘inherent design flaws’ of the human heart could become a thing of the past as new 3D printing technology …

News
Ema image

EMA to conduct major review into testosterone drugs

April 14, 2014
Research and Development, Sales and Marketing EMA, EU, Europe, heart, testosterone

The European Medicines Agency has started a review of testosterone-containing medicines as concerns grow that they may increase the risk …

News
Novartis image

FDA unconvinced on Novartis heart drug

March 26, 2014
Research and Development, Sales and Marketing FDA, Novartis, ahf, heart, serelaxin

The prospects of Novartis’ latest heart drug being approved in the US anytime soon appear to have been scuppered by …

News
Merck image

Reprieve for Merck’s vorapaxar

January 16, 2014
Sales and Marketing FDA, Merck, heart, vorapaxar

An FDA committee has voted that Merck’s troubled heart drug vorapaxar should be approved by the US regulator. The advisory …

News
gsk image

GSK heart disease drug fails late-stage trial

November 13, 2013
Sales and Marketing GSK, darapladib, heart, statin

GSK has said its investigational chronic coronary heart disease pill darapladib has failed to meet its primary endpoint in a …

News
brilinta image

EMA questions Brilinta data

November 8, 2013
Sales and Marketing Brilinta, EMA, astrazenca, heart, ticagrelor

The European Medicines Agency is demanding more information from AstraZeneca on its troubled heart pill Brilinta. This rounds off a …

News
Amgen image

Amgen signs Servier deal

July 11, 2013
Sales and Marketing Amgen, Servier, heart, procoloran

Amgen has gained rights in the US to two of Servier’s heart drugs: the novel, oral Procoralan and investigational Phase …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026